Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B.
Gao B, et al. Among authors: liu j, liu y, liu h, liu l.
J Hepatocell Carcinoma. 2023 Dec 13;10:2265-2276. doi: 10.2147/JHC.S443041. eCollection 2023.
J Hepatocell Carcinoma. 2023.
PMID: 38107541
Free PMC article.